| Fund | Shares Held | Position Value | Action (latest Q) |
|---|---|---|---|
| Berkshire Hathaway Warren Buffett | 31.76M | $3.61B | NEW |
| Citadel Ken Griffin | 590K | $66.99M | NEW |
| D.E. Shaw David Shaw | 541K | $61.47M | NEW |
| Renaissance Technologies Jim Simons (founder) | 172K | $19.48M | NEW |
| Marshall Wace | 3K | $295.4K | NEW |
DaVita Inc. is a leading healthcare provider specializing in kidney care services for patients with chronic kidney failure. The company operates primarily through its US Dialysis and Related Lab Services segment, delivering dialysis treatments at outpatient facilities across the United States, complemented by laboratory services essential for patient monitoring and care management. It also maintains Other-Ancillary Services and Strategic Initiatives, which encompass integrated kidney care solutions and innovative approaches to enhance patient outcomes. DaVita Inc. focuses on transforming care delivery through clinical quality leadership and advancements in kidney health management, serving as a key player in the renal care sector by providing comprehensive services that support patients' quality of life. Headquartered in Denver, Colorado, and founded in 1994, DaVita Inc. stands as the largest provider of kidney care services in the U.S., emphasizing operational excellence in dialysis and ancillary support.
Earnings calendar coming soon. Subscribe to get notified when DVA reports next.
Get earnings alerts →